Condition

Biliary Tract Cancers clinical trials and research

• 2Clinical trials
• 8Countries

All recruiting trials (2)

• Targeting driver oncogenes in biliary tract cancer with a personalized peptide vaccine plus durvalumab and tremelimumab

  This trial will test whether a personalized mutant peptide vaccine given with durvalumab and tremelimumab is safe and stimulates an immune response in people with advanced biliary tract cancer after first-line chemotherapy and anti–PD-(L)1 therapy.

  Recruiting Phase 1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland · NCT06564623

• Assessing the effects of ABBV-400 on advanced solid tumors

  This study is testing a new drug called ABBV-400 to see if it can help adults with advanced solid tumors like liver, pancreatic, and triple negative breast cancer feel better and manage their disease.

  Recruiting at 47 sites Phase 1 AbbVie · Duarte, California and 53 other locations · NCT06084481

Related topics

Quick answers

How many Biliary Tract Cancers clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (2 trials), Australia (1 trial), Israel (1 trial), Japan (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →